Pay in 4 interest-free payments of $6.00 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
Why does this matter for dosing
Retatrutide is studied as a multi-receptor agonist targeting GIP, GLP-1, and glucagon receptors, and is used in laboratory research focused on complex metabolic signaling
Id prefer to know exactly where the medication is coming from, and that might answer the question of how they are able to price their medications so low when compared to the industry standard
Selected publications: Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes The Lancet, 2023
Insurance may cover lipotropics, but only if you can prove youre using them to treat a medical condition
Diabetologia, 60(9), 15771585
US$ 24.28
US$ 26.04
US$ 21.36
US$ 23.20
US$ 27.41
